Sustained normalization of cardiac function by chelation therapy in thalassaemia major
- 1 December 1989
- journal article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 11 (4) , 299-307
- https://doi.org/10.1111/j.1365-2257.1989.tb00227.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJORThe Lancet, 1984
- Nuclear CardiologyNew England Journal of Medicine, 1981
- DECREASING IRON STORES DURING INTENSIVE CHELATION THERAPY *Annals of the New York Academy of Sciences, 1980
- Detection of Early Cardiac Dysfunction in Patients with Severe Beta-Thalassemia and Chronic Iron OverloadNew England Journal of Medicine, 1979
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974
- Iron in the heartThe American Journal of Medicine, 1971
- Clinical and Laboratory Studies on the Action of DesferrioxamineBritish Journal of Haematology, 1969
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964